MAI Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
MAI Capital Management's BMY Position: Q1 2026 in Review
MAI Capital Management increased its Bristol-Myers Squibb (BMY) stake by 13% in Q1 2026, buying an estimated $1.49M and bringing the position to 223,761 shares worth $13.6M. The position accounts for 0.08% of the portfolio, ranked #228.
MAI Capital Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $39.2M in Q4 2022. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- MAI Capital Management held 223,761 shares of Bristol-Myers Squibb worth $13.6M as of Q1 2026.
- MAI Capital Management bought 25,587 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.49M.
- Bristol-Myers Squibb made up 0.08% of MAI Capital Management's portfolio in Q1 2026, its #228 holding.
- MAI Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- MAI Capital Management's Bristol-Myers Squibb position peaked at $39.2M in Q4 2022.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.